ArticleThe oncologist2020

A Retrospective Analysis of the Safety and Activity of Lutetium-177-Prostate-Specific Membrane Antigen Radionuclide Treatment in Older Patients with Metastatic Castration-Resistant Prostate Cancer.

Raya Leibowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.